Archived Newsletters
-
03.02.26 -- Your Biomanufacturing STREAM: Scale-Up, Transfer, And Innovation Insights
3/2/2026
03/02/26 Outsourced Pharma Newsletter
-
03.02.26 -- A Biotech Business Model That's Investor-Friendly
3/2/2026
03/02/26 Outsourced Pharma Newsletter
-
02.28.26 -- At JP Morgan 2026, Few Showed Up For U.S. Manufacturing
2/28/2026
02/28/26
-
02.27.26 -- Global Partnerships Drive Biomanufacturing Innovation
2/27/2026
02/27/26 Outsourced Pharma Newsletter
-
02.27.26 -- The Quiet Case For Trusting CDMO Pricing
2/27/2026
02/27/26
-
02.26.26 -- The Top 10 Nations Redrawing The Outsourcing Map
2/26/2026
02/26/26
-
02.26.26 -- Unlocking Reliability And Speed In CGT
2/26/2026
02/26/26 Outsourced Pharma Newsletter
-
02.25.26 -- End-To-End ADC Manufacturing Works Best With Active Sponsor Oversight
2/25/2026
02/25/26
-
02.25.26 -- Ready to design a scalable, cost optimized viral vector workflow?
2/25/2026
02/25/26 Outsourced Pharma Newsletter
-
02.24.26 -- Optimizing CGT Development: Data-Driven, Platform-Based Solutions
2/24/2026
02/24/26 Outsourced Pharma Newsletter